Login | Register

MS Pill Shows Promise In Reducing Relapses

Two studies of a new pill for multiple sclerosis (MS) suggest it may reduce relapses and disability progression in people with the more common, relapsing-remitting form of the neurological condition, which accounts for around 85% of cases. The studies report the results of two phase 3 clinical trials, DEFINE and CONFIRM, evaluating oral BG-12 (dimethyl fumarate) for the treatment of MS...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *